SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037458
Filing Date
2023-08-03
Accepted
2023-08-02 19:29:22
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20230630.htm   iXBRL 10-Q 2643206
2 EX-10.1 acad-ex10_1.htm EX-10.1 1200979
3 EX-31.1 acad-ex31_1.htm EX-31.1 13460
4 EX-31.2 acad-ex31_2.htm EX-31.2 13715
5 EX-32.1 acad-ex32_1.htm EX-32.1 9852
6 EX-32.2 acad-ex32_2.htm EX-32.2 9910
  Complete submission text file 0000950170-23-037458.txt   11116295

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acad-20230630_def.xml EX-101.DEF 151548
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20230630_pre.xml EX-101.PRE 293802
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acad-20230630_cal.xml EX-101.CAL 54086
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20230630_lab.xml EX-101.LAB 394575
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20230630.xsd EX-101.SCH 51331
62 EXTRACTED XBRL INSTANCE DOCUMENT acad-20230630_htm.xml XML 2203087
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 231137591
SIC: 2834 Pharmaceutical Preparations